Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-004190
Filing Date
2009-04-15
Accepted
2009-04-15 17:26:42
Documents
14
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2192342z10-k.htm 10-K 1126898
2 EXHIBIT 10.13 a2192342zex-10_13.htm EX-10.13 475354
3 EXHIBIT 10.14 a2192342zex-10_14.htm EX-10.14 149820
4 EXHIBIT 10.15 a2192342zex-10_15.htm EX-10.15 93909
5 EXHIBIT 10.16 a2192342zex-10_16.htm EX-10.16 122680
6 EXHIBIT 10.17 a2192342zex-10_17.htm EX-10.17 30442
7 EXHIBIT 10.18 a2192342zex-10_18.htm EX-10.18 86672
8 EXHIBIT 10.19 a2192342zex-10_19.htm EX-10.19 114012
9 EXHIBIT 21 a2192342zex-21.htm EX-21 1902
10 EXHIBIT 23 a2192342zex-23.htm EX-23 4373
11 EXHIBIT 31.1 a2192342zex-31_1.htm EX-31.1 7904
12 EXHIBIT 31.2 a2192342zex-31_2.htm EX-31.2 7928
13 EXHIBIT 32.1 a2192342zex-32_1.htm EX-32.1 4398
14 EXHIBIT 32.2 a2192342zex-32_2.htm EX-32.2 4418
  Complete submission text file 0001047469-09-004190.txt   2232243
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 09752086
SIC: 2834 Pharmaceutical Preparations